464 related articles for article (PubMed ID: 18245177)
21. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults.
Greenberg WM; Benedict MM; Doerfer J; Perrin M; Panek L; Cleveland WL; Javitt DC
J Psychiatr Res; 2009 Mar; 43(6):664-70. PubMed ID: 19046587
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.
Franklin ME; Abramowitz JS; Kozak MJ; Levitt JT; Foa EB
J Consult Clin Psychol; 2000 Aug; 68(4):594-602. PubMed ID: 10965635
[TBL] [Abstract][Full Text] [Related]
23. Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients.
Vulink NC; Denys D; Fluitman SB; Meinardi JC; Westenberg HG
J Clin Psychiatry; 2009 Jul; 70(7):1001-8. PubMed ID: 19497245
[TBL] [Abstract][Full Text] [Related]
24. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
Storch EA; Murphy TK; Goodman WK; Geffken GR; Lewin AB; Henin A; Micco JA; Sprich S; Wilhelm S; Bengtson M; Geller DA
Biol Psychiatry; 2010 Dec; 68(11):1073-6. PubMed ID: 20817153
[TBL] [Abstract][Full Text] [Related]
25. Electroacupuncture for refractory obsessive-compulsive disorder: a pilot waitlist-controlled trial.
Zhang ZJ; Wang XY; Tan QR; Jin GX; Yao SM
J Nerv Ment Dis; 2009 Aug; 197(8):619-22. PubMed ID: 19684500
[TBL] [Abstract][Full Text] [Related]
26. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis.
Fisher PL; Wells A
Behav Res Ther; 2005 Dec; 43(12):1543-58. PubMed ID: 16239151
[TBL] [Abstract][Full Text] [Related]
27. A pilot study of moderate-intensity aerobic exercise for obsessive compulsive disorder.
Brown RA; Abrantes AM; Strong DR; Mancebo MC; Menard J; Rasmussen SA; Greenberg BD
J Nerv Ment Dis; 2007 Jun; 195(6):514-20. PubMed ID: 17568300
[TBL] [Abstract][Full Text] [Related]
28. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
[TBL] [Abstract][Full Text] [Related]
29. Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave AM; Tolin DF; Stevens MC
J Clin Psychiatry; 2012 Sep; 73(9):1179-86. PubMed ID: 23059145
[TBL] [Abstract][Full Text] [Related]
30. Obsessive-compulsive disorder: identification, neurobiology, and treatment.
Neel JL; Stevens VM; Stewart JE
J Am Osteopath Assoc; 2002 Feb; 102(2):81-6. PubMed ID: 11866396
[TBL] [Abstract][Full Text] [Related]
31. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
Buchanan RW; Javitt DC; Marder SR; Schooler NR; Gold JM; McMahon RP; Heresco-Levy U; Carpenter WT
Am J Psychiatry; 2007 Oct; 164(10):1593-602. PubMed ID: 17898352
[TBL] [Abstract][Full Text] [Related]
32. d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder.
de Leeuw AS; van Megen HJ; Kahn RS; Westenberg HG
Eur Psychiatry; 2017 Feb; 40():38-44. PubMed ID: 27837671
[TBL] [Abstract][Full Text] [Related]
33. Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.
Rothbaum BO
Am J Psychiatry; 2008 Mar; 165(3):293-6. PubMed ID: 18316423
[No Abstract] [Full Text] [Related]
34. Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder.
O'Connor KP; Aardema F; Robillard S; Guay S; Pélissier MC; Todorov C; Borgeat F; Leblanc V; Grenier S; Doucet P
Acta Psychiatr Scand; 2006 May; 113(5):408-19. PubMed ID: 16603032
[TBL] [Abstract][Full Text] [Related]
35. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.
Litz BT; Salters-Pedneault K; Steenkamp MM; Hermos JA; Bryant RA; Otto MW; Hofmann SG
J Psychiatr Res; 2012 Sep; 46(9):1184-90. PubMed ID: 22694905
[TBL] [Abstract][Full Text] [Related]
36. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
[TBL] [Abstract][Full Text] [Related]
37. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
Poyurovsky M; Faragian S; Shabeta A; Kosov A
Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
[TBL] [Abstract][Full Text] [Related]
39. Long-term course of obsessive-compulsive disorder treated in adolescence.
Bolton D; Luckie M; Steinberg D
J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1441-50. PubMed ID: 8543511
[TBL] [Abstract][Full Text] [Related]
40. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.
Heresco-Levy U; Javitt DC; Gelfin Y; Gorelik E; Bar M; Blanaru M; Kremer I
J Affect Disord; 2006 Jul; 93(1-3):239-43. PubMed ID: 16677714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
